Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| conventional visit | Active Comparator | Regular outpatient visit |
|
| phone visit | Experimental | Remote visit via phone |
|
| video visit | Experimental | Remote visit via videochat |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EDSS | Other | Neurological Exam - EDSS (Expanded Disability Status Scale) |
|
| Measure | Description | Time Frame |
|---|---|---|
| TMPQ | Telemedicine Perception questionnaire (17-85, higher scores are better) | 1 week after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| PPSM | Patient and Physician Satisfaction with monitoring (6-30, higher scores are better) | 1 week after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Ancillary Analyses | Subgroup analyses comparing scores on the TMPQ above and below the median (Telemedicine Perception questionnaire, 17-85 points, higher scores are better) with clinical characteristics (EDSS and MSIS and Age) | immediately after the intervention |
| Empirical Questionnaire |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patrick Altmann, MD PhD | Medical University of Vienna | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Vienna | Vienna | 1090 | Austria |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35847524 | Derived | Altmann P, Leutmezer F, Ponleitner M, Ivkic D, Krajnc N, Rommer PS, Berger T, Bsteh G. Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial. Digit Health. 2022 Jul 11;8:20552076221112154. doi: 10.1177/20552076221112154. eCollection 2022 Jan-Dec. |
Not provided
Not provided
Data will be shared upon reasonable request and through our local ERB.
Upon request and for 1 month
reasonable request and upon approval of our local ERB
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000071066 | Patient Reported Outcome Measures |
| ID | Term |
|---|---|
| D019538 | Health Care Surveys |
| D011795 | Surveys and Questionnaires |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
Not provided
Not provided
Randomized controlled trial
Not provided
Not provided
Not provided
Not provided
| Discussion of symptoms, Patient reported outcome (MSIS) | Other | Patients will be asked about their wellbeing |
|
Participants are given an opportunity to openly provide feedback |
| 1 week after intervention |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D008919 |
| Investigative Techniques |
| D006302 | Health Services Research |
| D006285 | Health Planning |
| D004472 | Health Care Economics and Organizations |
| D063868 | Patient Outcome Assessment |
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
| D017531 | Health Care Evaluation Mechanisms |
| D011634 | Public Health |
| D004778 | Environment and Public Health |